3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
105
Leukemia
65
Burkitt Lymphoma
26
Lymphoma
18
Leukemia, Biphenotypic, Acute
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Promyelocytic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasm, Residual
5
Leukemia, Myeloid, Acute
5
Down Syndrome
4
Neoplasms
3
Leukemia, T-Cell
3
Dendritic Cell Sarcoma, Interdigitating
3
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Glioblastoma
2
Thrombocytopenia
1
Rare Diseases
1
Philadelphia Chromosome
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neutropenia
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Mucositis
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Interventions
Paclitaxel
326
Carboplatin
318
Bevacizumab
167
Gemcitabine
106
pembrolizumab
100
liposomal doxorubicin
100
Cyclophosphamide
94
Topotecan
93
Cisplatin
89
olaparib
86
niraparib
60
Docetaxel
56
Taxes
52
Doxorubicin
50
Drug Therapy
42
fludarabine
39
Filgrastim
39
Nivolumab
37
Etoposide
32
Specimen Handling
31
Magnetic Resonance Spectroscopy
29
Immunoglobulin G
27
Disulfides
27
Peripheral Blood Stem Cell Transplantation
26
Albumin-Bound Paclitaxel
25
durvalumab
24
aldesleukin
24
Hyperthermic Intraperitoneal Chemotherapy
24
Oxaliplatin
23
Biopsy
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Ovarian Neoplasms
×
Mercaptopurine
×
Clear all
NCT01432145
2019-07-09
6MP
University of Oxford
Phase 2
Completed
74 enrolled
13 charts